Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Last thought before sleeping
View:
Post by N0taP00p on Nov 30, 2022 12:08am

Last thought before sleeping

Where's the stock headed tomorrow?  Set aside all your conspiracy theories for the moment. Unless this company goes on a PR offensive using available means (Dr Kamat, Dr. MacFarland, etc), will people really understand how this compares with other solutions?  Many of you are assuming the data will  pull, no compel, the analyst moths to the light. I am not so sure but hope so.  My gut says that this will run if it gets into the FDAs Frontrunner program. Hooo boy, wouldn't that be fun.
Comment by Legit62 on Nov 30, 2022 5:42am
I would want to believe that our name is spreading in the urology sector, which will then spread to other sectors of cancer treatment arena. But i also agree a little more PR would be great, Im also sure big Pharma is very well aware of us and its just a matter of time before they scoop in. A big fat buyout in spring would be great, less thinking involved for us
Comment by Legit62 on Nov 30, 2022 5:45am
Project FrontRunner aims to improve the evidence base for cancer therapies by promoting trial designs and clinical development and regulatory approaches (e.g., accelerated approval pathway) that help generate data from gold standard randomized controlled trials to support the safe and effective use of cancer therapies ...Nov 9, 2022
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250